{"id":39057,"date":"2026-04-30T10:39:20","date_gmt":"2026-04-30T10:39:20","guid":{"rendered":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/"},"modified":"2026-04-30T10:39:20","modified_gmt":"2026-04-30T10:39:20","slug":"descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma","status":"publish","type":"post","link":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/","title":{"rendered":"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma"},"content":{"rendered":"<p>Un equip del Cl\u00ednic\u2011IDIBAPS, en el marc del Cl\u00ednic Barcelona Comprehensive Cancer Centre, ha participat en un estudi internacional que descriu per primera vegada l\u2019activitat antitumoral d\u2019una nova generaci\u00f3 d\u2019inhibidors de RAS en models precl\u00ednics de colangiocarcinoma, un c\u00e0ncer de les vies biliars amb mal pron\u00f2stic i poques opcions terap\u00e8utiques.<\/p>","protected":false},"excerpt":{"rendered":"<p>Un equip del Cl\u00ednic\u2011IDIBAPS, en el marc del Cl\u00ednic Barcelona Comprehensive Cancer Centre, ha participat en un estudi internacional que descriu per primera vegada l\u2019activitat antitumoral d\u2019una nova generaci\u00f3 d\u2019inhibidors de RAS en models precl\u00ednics de colangiocarcinoma, un c\u00e0ncer de les vies biliars amb mal pron\u00f2stic i poques opcions terap\u00e8utiques.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"tipo":[],"class_list":{"0":"post-39057","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-uncategorized"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma - Recerca en salut<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma - Recerca en salut\" \/>\n<meta property=\"og:description\" content=\"Un equip del Cl\u00ednic\u2011IDIBAPS, en el marc del Cl\u00ednic Barcelona Comprehensive Cancer Centre, ha participat en un estudi internacional que descriu per primera vegada l\u2019activitat antitumoral d\u2019una nova generaci\u00f3 d\u2019inhibidors de RAS en models precl\u00ednics de colangiocarcinoma, un c\u00e0ncer de les vies biliars amb mal pron\u00f2stic i poques opcions terap\u00e8utiques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/\" \/>\n<meta property=\"og:site_name\" content=\"Recerca en salut\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-30T10:39:20+00:00\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/\"},\"author\":{\"name\":\"Redacci\u00f3\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9de78768f9e1608c4e3acede8e5f91c4\"},\"headline\":\"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma\",\"datePublished\":\"2026-04-30T10:39:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/\"},\"wordCount\":76,\"commentCount\":0,\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/\",\"name\":\"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma - Recerca en salut\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#website\"},\"datePublished\":\"2026-04-30T10:39:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9de78768f9e1608c4e3acede8e5f91c4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2026\\\/04\\\/30\\\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#website\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/\",\"name\":\"Recerca en salut\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9de78768f9e1608c4e3acede8e5f91c4\",\"name\":\"Redacci\u00f3\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3\"},\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/author\\\/npenin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma - Recerca en salut","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/","og_locale":"es_ES","og_type":"article","og_title":"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma - Recerca en salut","og_description":"Un equip del Cl\u00ednic\u2011IDIBAPS, en el marc del Cl\u00ednic Barcelona Comprehensive Cancer Centre, ha participat en un estudi internacional que descriu per primera vegada l\u2019activitat antitumoral d\u2019una nova generaci\u00f3 d\u2019inhibidors de RAS en models precl\u00ednics de colangiocarcinoma, un c\u00e0ncer de les vies biliars amb mal pron\u00f2stic i poques opcions terap\u00e8utiques.","og_url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/","og_site_name":"Recerca en salut","article_published_time":"2026-04-30T10:39:20+00:00","author":"Redacci\u00f3","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Redacci\u00f3"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/#article","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/"},"author":{"name":"Redacci\u00f3","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4"},"headline":"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma","datePublished":"2026-04-30T10:39:20+00:00","mainEntityOfPage":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/"},"wordCount":76,"commentCount":0,"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/","name":"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma - Recerca en salut","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website"},"datePublished":"2026-04-30T10:39:20+00:00","author":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4"},"breadcrumb":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2026\/04\/30\/descriuen-per-primera-vegada-lactivitat-antitumoral-dinhibidors-ras-en-models-preclinics-de-colangiocarcinoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/diarisanitat.cat\/recerca-en-salut\/"},{"@type":"ListItem","position":2,"name":"Descriuen per primera vegada l\u2019activitat antitumoral d\u2019inhibidors RAS en models precl\u00ednics de colangiocarcinoma"}]},{"@type":"WebSite","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/","name":"Recerca en salut","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diarisanitat.cat\/recerca-en-salut\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9de78768f9e1608c4e3acede8e5f91c4","name":"Redacci\u00f3","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e952ad62e08be1daabaefebd12d26c1e5fbfd687693aaa066db2433a21638ad8?s=96&d=mm&r=g","caption":"Redacci\u00f3"},"url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/author\/npenin\/"}]}},"_links":{"self":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/39057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/comments?post=39057"}],"version-history":[{"count":0,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/39057\/revisions"}],"wp:attachment":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/media?parent=39057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/categories?post=39057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tags?post=39057"},{"taxonomy":"tipo","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tipo?post=39057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}